Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth
Clinical trial NCT00685503 · COMPLETED
Trial details
- NCT number
- NCT00685503
- Sponsor
- National Eye Institute (NEI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-21
- Primary completion
- 2011-04-12
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.